Drug reference
Primary immunisation ▶BY INTRAMUSCULAR INJECTION ▶Child 2 months–9 years: 0.5 mL every month for 3 doses l UNLICENSED USE Infanrix-IPV+ Hib ® not licensed for use in children over 36 months; Pediacel ® not licensed in children over 4 years. However, the Department of Health recommends that these be used for children up to 10 years.
PDF pages 1403, 1404
Available as part of childhood schedule from health organisations or ImmForm.
PDF page 1404
▶Common or very common Crying abnormal. drowsiness. restlessness ▶Uncommon Cough. extensive swelling of vaccinated limb. increased risk of infection. rhinorrhoea ▶Frequency not known Angioedema. apnoea. hypotonic- hyporesponsiveness episode. seizure SIDE-EFFECTS, FURTHER INFORMATION The incidence of local and systemic reactions is lower with acellular pertussis vaccines than with whole-cell pertussis vaccines used previously. Compared with primary vaccination, injection site reactions are more common with booster doses of vaccines containing acellular pertussis. Public Health England has advised (2016) that the vaccine should not be withheld from children with a history to a preceding dose of: fever, irrespective of Vaccines severity; hypotonic-hyporesonsive episodes; persistent crying or screaming for more than 3 hours; severe local reaction, irrespective of extent.
PDF page 1404
There can be variation in the licensing of different medicines containing the same drug. Powder and suspension for suspension for injection ▶Infanrix-IPV + Hib (GlaxoSmithKline UK Ltd) Infanrix-IPV + Hib vaccine powder and suspension for suspension for injection 0.5ml pre-filled syringes | 1 pre-filled disposable injection P £27.86 VACCINES › BACTERIAL VACCINES eiiii F 1379
PDF page 1404
0.5 mL every month for 3 doses
First-line fragment. Read the complete Indications and Dose section above.
PDF page 1403
